Portal de Periódicos da CAPES

Biparametric MRI of the prostate

2017; Volume: 43; Issue: 4 Linguagem: Inglês

10.5152/tud.2017.06978

2149-3057

Michele Scialpi, Alfredo D’Andrea, Eugenio Martorana, Corrado Maria Malaspina, Maria Cristina Aisa, Maria Napoletano, Emanuele Orlandi, Valeria Rondoni, Pietro Scialpi, Diamante Pacchiarini, Diego Palladino, Michele Dragone, Gian Carlo Di Renzo, Annalisa Simeone, Giampaolo Bianchi, Luca Brunese,

Urologic and reproductive health conditions

Biparametric Magnetic Resonance Imaging (bpMRI) of the prostate combining both morphologic T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) is emerging as an alternative to multiparametric MRI (mpMRI) to detect, to localize and to guide prostatic targeted biopsy in patients with suspicious prostate cancer (PCa). BpMRI overcomes some limitations of mpMRI such as the costs, the time required to perform the study, the use of gadolinium-based contrast agents and the lack of a guidance for management of score 3 lesions equivocal for significant PCa. In our experience the optimal and similar clinical results of the bpMRI in comparison to mpMRI are essentially related to the DWI that we consider the dominant sequence for detection suspicious PCa both in transition and in peripheral zone. In clinical practice, the adoption of bpMRI standardized scoring system, indicating the likelihood to diagnose a clinically significant PCa and establishing the management of each suspicious category (from 1 to 4), could represent the rationale to simplify and to improve the current interpretation of mpMRI based on Prostate Imaging and Reporting Archiving Data System version 2 (PI-RADS v2). In this review article we report and describe the current knowledge about bpMRI in the detection of suspicious PCa and a simplified PI-RADS based on bpMRI for management of each suspicious PCa categories to facilitate the communication between radiologists and urologists.